Self‐Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial
Authors:
- 1 November 2016
- journal article
- research article
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 64 (12) , 2472-2478
Abstract
Objectives: To investigate the association between baseline sleep apnea and risk of incident dementia in the Prevention of Alzheimer's Disease with Vitamin E and Selenium ( PREADV i SE ) study and to explore whether the association depends on apolipoprotein E ( APOE ) ɛ 4 allele status. Design: Secondary analysis based on data collected during PREADV i SE . Setting: Participants were assessed at 128 local clinical study sites during the clinical trial phase and later were followed by telephone from a centralized location. Participants: Men enrolled in PREADV i SE (without dementia or other active neurological conditions that affect cognition such as major psychiatric disorders, including depression; N = 7,547). Measurements: Participants were interviewed at baseline for sleep apnea. The Memory Impairment Screen ( MIS ) was administered to each participant annually. Subjects who failed this initial screen were tested with secondary screening tests. Medical history and medication use were determined, and the AD 8 dementia screening instrument was used. Results: The effect of self‐reported sleep apnea on dementia risk depended on APOE ɛ 4 status. When the allele was absent, baseline self‐reported sleep apnea was associated with a 66% higher risk of developing dementia (95% confidence interval = 2–170%), whereas self‐reported sleep apnea conferred no additional risk for participants with an ɛ 4 allele. Conclusion: Sleep apnea may increase risk of dementia in the absence of APOE ɛ 4. This may help inform prevention strategies for dementia or AD in older men with sleep apnea. Registration: PREADV i SE is registered at ClinicalTrials.gov: NCT 00040378.Keywords
Funding Information
- National Institute on Aging (R01 AG019421, R01 AG038651, P30 AG028383)
- National Cancer Institute (CA37429, UM1 CA182883)
This publication has 50 references indexed in Scilit:
- Sleep Apnea and the Risk of Dementia: A Population-Based 5-Year Follow-Up Study in TaiwanPLOS ONE, 2013
- Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of β-Amyloid in Mice with Alzheimer’s Disease PathologyScience Translational Medicine, 2012
- Age and Sleep Disturbances Among American Men And Women: Data From the U.S. Behavioral Risk Factor Surveillance SystemSLEEP, 2012
- Associations Between Sleep Architecture and Sleep‐Disordered Breathing and Cognition in Older Community‐Dwelling Men: The Osteoporotic Fractures in Men Sleep StudyJournal of the American Geriatrics Society, 2011
- The projected effect of risk factor reduction on Alzheimer's disease prevalenceThe Lancet Neurology, 2011
- Sleep-Disordered Breathing, Hypoxia, and Risk of Mild Cognitive Impairment and Dementia in Older WomenJAMA, 2011
- Ginkgo biloba for Preventing Cognitive Decline in Older AdultsA Randomized TrialJAMA, 2009
- Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake CycleScience, 2009
- Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other CancersJAMA, 2009
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008